CARMIEL, Israel--(BUSINESS WIRE)--Protalix BioTherapeutics, Inc. (Amex: PLX), announced today that it will present at the Oppenheimer Small and Mid Cap Clinical and Regulatory Conference in New York City on August 4, 2008. The conference is being held at Oppenheimer’s offices located at 300 Madison Ave. Dr. David Aviezer, Protalix’s President and Chief Executive Officer will give a corporate overview at 9:30 AM ET and will participate on the “Designing a Pivotal Program with an Eye Towards Approval” panel at 9:55 AM ET.
